Chalazion
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Bausch + LombNJ - Bridgewater
1 program1
loteprednol etabonate/tobramycin opthalmic suspensionPhase 41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bausch + Lombloteprednol etabonate/tobramycin opthalmic suspension
LumenisSham IPL
LumenisOptiLIGHT
Clinical Trials (3)
Total enrollment: 152 patients across 3 trials
Pediatric Zylet Safety and Efficacy Study
Start: Nov 2006Est. completion: Jun 2009108 patients
Phase 4Completed
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
Start: Feb 2026Est. completion: Dec 202640 patients
N/ANot Yet Recruiting
Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
Start: Sep 2025Est. completion: Dec 20254 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space